Explore expert strategies to overcome development hurdles, forge strategic partnerships, and unlock the full potential of cell and gene therapies.
Join Form Bio and PacBio for a relaxing evening al fresco at The Lighthouse, a carbon-neutral venue conveniently located in South San Francisco.
The World Orphan Drug Congress USA is the defining event for the rare disease and orphan drug space globally. Returning to the Boston Convention & Exhibition Center April 23-25, this upcoming event will cover conversations on next generation therapies, clinical development and regulatory, global market & patient access, advanced therapies, rare disease advocacy, and more!
Advanced Therapies 2024 unites leaders from across the world, to give insight and to promote collaboration to accelerate the development & commercialisation of next generation medicines, bring them to market and help change patient lives. For the past 18 years, the Advanced Therapies Congress has evolved and grown into the leading cell and gene conference and exhibition globally, with hundreds of speakers, thousands of attendees and hundreds of networking opportunities.
Now in its 10th year, the Immuno-Oncology 360° Summit taking place February 27-29, 2024 in Brooklyn, NY offers an unparalleled opportunity to hear from stakeholders representing both the science and business communities who report on the latest data impacting IO to fight a wider range of cancers. Learn more at https://io360summit.com/
Applications for BioTools Innovator, the premier accelerator for life science tools, enabling biotechnologies, and diagnostics platforms are now open! The BTI program isn’t just about cutting-edge biotechnology; it’s about building lifelong relationships with industry leaders, mentors, and fellow innovators.
Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives.
Europe’s Most Exciting Orphan Drug Event returns in 2023